These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. [The evolution of the concepts of systemic scleroderma]. Guseva NG Ter Arkh; 1995; 67(5):50-3. PubMed ID: 7638781 [No Abstract] [Full Text] [Related]
28. [Developing a clinical classification of systemic scleroderma]. Guseva NG Vopr Revm; 1969; 9(2):14-8. PubMed ID: 5363860 [No Abstract] [Full Text] [Related]
29. Potential benefit of statins for vascular disease in systemic sclerosis. Kuwana M Curr Opin Rheumatol; 2006 Nov; 18(6):594-600. PubMed ID: 17053504 [TBL] [Abstract][Full Text] [Related]
30. Statins and the vasculopathy of systemic sclerosis: potential therapeutic agents? Derk CT; Jimenez SA Autoimmun Rev; 2006 Jan; 5(1):25-32. PubMed ID: 16338208 [TBL] [Abstract][Full Text] [Related]
31. Variation of urinary acid glycosaminoglycan and collagen metabolite excretion with disease activity in generalized scleroderma. Blumenkrantz N; Asboe-Hansen G Acta Derm Venereol; 1980; 60(1):39-43. PubMed ID: 6153832 [TBL] [Abstract][Full Text] [Related]
32. [Hormones--underestimated problem in dermatology. Part 2. Autoimmune disease]. Damasiewicz-Bodzek A; Kos-Kudła B Pol Merkur Lekarski; 2002 Jun; 12(72):546-50. PubMed ID: 12362680 [TBL] [Abstract][Full Text] [Related]
33. [Relation of bone pathology to vascular changes]. SEYSS R Radiol Clin; 1954 May; 23(3):129-36. PubMed ID: 13186100 [No Abstract] [Full Text] [Related]
34. Fli1 deficiency and beyond: a unique pathway linking peripheral vasculopathy and dermal fibrosis in systemic sclerosis. Manetti M Exp Dermatol; 2015 Apr; 24(4):256-7. PubMed ID: 25529866 [No Abstract] [Full Text] [Related]
35. The development of systemic sclerosis (scleroderma) following augmentation mammoplasty. Appleton BE; Lee P J Rheumatol; 1993 Jun; 20(6):1052-4. PubMed ID: 8350312 [TBL] [Abstract][Full Text] [Related]
36. [Progressive systemic sclerosis. A diagnostic problem]. Posada de la Paz M; Martínez L de Letona J; Masa Vázquez C; Ruiz Galiana J; Pérez Alvarez R; Díez García F; Pérez Maestu R Rev Clin Esp; 1983 Sep; 170(6):237-41. PubMed ID: 6361922 [No Abstract] [Full Text] [Related]
37. [Systemic sclerosis (scleroderma): etiology and pathogenesis--where are we today?]. Stoll T; Brühlmann P; Fontana A; Gmür J; Michel BA Schweiz Med Wochenschr; 1994 Feb; 124(5):193-203. PubMed ID: 8128201 [TBL] [Abstract][Full Text] [Related]
38. Local regulation of blood flow in cutaneous and subcutaneous tissue in patients with generalized scleroderma. Kristensen JK Acta Derm Venereol Suppl (Stockh); 1980; Suppl 90():1-39. PubMed ID: 6932795 [No Abstract] [Full Text] [Related]
40. [Characteristics of clinical symptoms and course of systemic scleroderma depending on sex and age of onset]. Volkov AV; Starovoĭtova MN; Guseva NG Ter Arkh; 2004; 76(5):7-11. PubMed ID: 15230123 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]